MJP Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $482K | Buy |
19,874
+2,897
| +17% | +$70.2K | 0.07% | 127 |
|
|
2025
Q1 | $430K | Buy |
16,977
+2,153
| +15% | +$54.6K | 0.08% | 129 |
|
|
2024
Q4 | $393K | Sell |
14,824
-118
| -0.8% | -$3.13K | 0.07% | 136 |
|
|
2024
Q3 | $432K | Sell |
14,942
-564
| -4% | -$16.3K | 0.08% | 127 |
|
|
2024
Q2 | $434K | Sell |
15,506
-636
| -4% | -$17.8K | 0.09% | 127 |
|
|
2024
Q1 | $448K | Buy |
16,142
+2,285
| +16% | +$63.4K | 0.1% | 118 |
|
|
2023
Q4 | $399K | Buy |
13,857
+4,749
| +52% | +$137K | 0.11% | 94 |
|
|
2023
Q3 | $302K | Sell |
9,108
-10,778
| -54% | -$357K | 0.09% | 99 |
|
|
2023
Q2 | $729K | Sell |
19,886
-1,810
| -8% | -$66.4K | 0.24% | 47 |
|
|
2023
Q1 | $885K | Sell |
21,696
-512
| -2% | -$20.9K | 0.27% | 35 |
|
|
2022
Q4 | $1.14M | Buy |
22,208
+1,075
| +5% | +$55.1K | 0.33% | 38 |
|
|
2022
Q3 | $925K | Sell |
21,133
-1,133
| -5% | -$49.6K | 0.28% | 38 |
|
|
2022
Q2 | $1.17M | Buy |
22,266
+2,406
| +12% | +$126K | 0.33% | 33 |
|
|
2022
Q1 | $1.03M | Buy |
19,860
+402
| +2% | +$20.8K | 0.26% | 46 |
|
|
2021
Q4 | $1.1M | Buy |
19,458
+3,096
| +19% | +$175K | 0.33% | 43 |
|
|
2021
Q3 | $704K | Buy |
16,362
+309
| +2% | +$13.3K | 0.24% | 56 |
|
|
2021
Q2 | $629K | Buy |
16,053
+1,677
| +12% | +$65.7K | 0.21% | 56 |
|
|
2021
Q1 | $521K | Buy |
14,376
+1,401
| +11% | +$50.8K | 0.21% | 61 |
|
|
2020
Q4 | $478K | Buy |
+12,975
| New | +$478K | 0.2% | 62 |
|